Tomblyn, M. B., Goldman, B. H., Thomas, C. R., Benedetti, J. K., Lenz, H., Mehta, V., . . . Blanke, C. D. (2012). CETUXIMAB PLUS CISPLATIN, IRINOTECAN, AND THORACIC RADIOTHERAPY AS DEFINITIVE TREATMENT FOR LOCALLY ADVANCED, UNRESECTABLE ESOPHAGEAL CANCER: A PHASE II STUDY OF THE SWOG (S0414).
Chicago Style citaatTomblyn, Michael B., et al. CETUXIMAB PLUS CISPLATIN, IRINOTECAN, AND THORACIC RADIOTHERAPY AS DEFINITIVE TREATMENT FOR LOCALLY ADVANCED, UNRESECTABLE ESOPHAGEAL CANCER: A PHASE II STUDY OF THE SWOG (S0414). 2012.
MLA citatieTomblyn, Michael B., et al. CETUXIMAB PLUS CISPLATIN, IRINOTECAN, AND THORACIC RADIOTHERAPY AS DEFINITIVE TREATMENT FOR LOCALLY ADVANCED, UNRESECTABLE ESOPHAGEAL CANCER: A PHASE II STUDY OF THE SWOG (S0414). 2012.